Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
In BriefThis Month in JNM

This Month in JNM

Journal of Nuclear Medicine January 2017, 58 (1) 8A;
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 58 no. 1 8A
PubMed 
28062716

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online January 3, 2017.

Copyright & Usage 
© 2017 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: January 2017 to May 2025

AbstractFullPdf
Jan 20174214597
Feb 201722517
Mar 20171177
Apr 201701514
May 20170105
Jun 20170248
Jul 20170449
Aug 201706818
Sep 201705219
Oct 201706420
Nov 201706316
Dec 201704519
Jan 201805418
Feb 201804521
Mar 201804315
Apr 201807925
May 201806019
Jun 201803214
Jul 201802212
Aug 20180298
Sep 201802710
Oct 20180459
Nov 201802811
Dec 20180209
Jan 20190439
Feb 201903610
Mar 20190405
Apr 20190276
May 20190267
Jun 20190186
Jul 20190236
Aug 20190253
Sep 20190164
Oct 20190368
Nov 20190307
Dec 20190191
Jan 20200314
Feb 20200188
Mar 20200224
Apr 20200181
May 20200182
Jun 20200102
Jul 2020052
Aug 2020061
Sep 20200194
Oct 20200116
Nov 20200191
Dec 20200201
Jan 2021077
Feb 2021031
Mar 2021010
Apr 20210104
May 2021051
Jun 2021081
Jul 20210127
Aug 2021062
Sep 2021010
Oct 2021058
Nov 2021040
Dec 2021071
Jan 2022062
Feb 2022010
Mar 2022062
Apr 2022011
May 2022060
Jun 2022020
Jul 20220471
Aug 2022041
Sep 2022031
Oct 2022021
Nov 2022041
Dec 2022071
Jan 20230200
Feb 2023085
Mar 2023071
Apr 20230130
May 20230103
Jun 2023025
Jul 2023035
Aug 2023015
Sep 2023042
Oct 2023072
Nov 2023030
Dec 20230120
Jan 2024070
Feb 2024020
Mar 2024011
Apr 20240137
May 20240120
Jun 20240104
Jul 20240146
Aug 20240295
Sep 20240143
Oct 2024051
Nov 2024090
Dec 20240142
Jan 2025070
Feb 20250133
Mar 2025035
Apr 2025085
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 58 (1)
Journal of Nuclear Medicine
Vol. 58, Issue 1
January 1, 2017
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
This Month in JNM
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
This Month in JNM
Journal of Nuclear Medicine Jan 2017, 58 (1) 8A;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
This Month in JNM
Journal of Nuclear Medicine Jan 2017, 58 (1) 8A;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • Dual-Modality Imaging of Prostate Cancer with a Fluorescent and Radiogallium-Labeled Gastrin-Releasing Peptide Receptor Antagonist
  • SNMMI Comment on the 2016 Society of Surgical Oncology “Choosing Wisely” Recommendation on the Use of PET/CT in Colorectal Cancer
  • German Multicenter Study Investigating 177Lu-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients
  • 18F-FDG PET for Measurement of Response and Prediction of Outcome to Relapsed or Refractory Mantle Cell Lymphoma Therapy with Bendamustine–Rituximab
  • Tumor-Absorbed Dose for Non-Hodgkin Lymphoma Patients Treated with the Anti-CD37 Antibody Radionuclide Conjugate 177Lu-Lilotomab Satetraxetan
  • 18F-Fluorosulfate for PET Imaging of the Sodium–Iodide Symporter: Synthesis and Biologic Evaluation In Vitro and In Vivo
  • 123I-Iodobenzovesamicol SPECT Imaging of Cholinergic Systems in Dementia with Lewy Bodies
  • Theranostic Perspectives in Prostate Cancer with the Gastrin-Releasing Peptide Receptor Antagonist NeoBOMB1: Preclinical and First Clinical Results
  • Liposomal Treatment of Experimental Arthritis Can Be Monitored Noninvasively with a Radiolabeled Anti–Fibroblast Activation Protein Antibody
  • Matrix Metalloproteinase–Targeted Imaging of Lung Inflammation and Remodeling
  • Epileptic Activity Increases Cerebral Amino Acid Transport Assessed by 18F-Fluoroethyl-l-Tyrosine Amino Acid PET: A Potential Brain Tumor Mimic
  • From NETTER to PETTER: PSMA-Targeted Radioligand Therapy
  • Subjecting Radiologic Imaging to the Linear No-Threshold Hypothesis: A Non Sequitur of Non-Trivial Proportion
  • What We Observe In Vivo Is Not Always What We See In Vitro: Development and Validation of 11C-JNJ-42491293, A Novel Radioligand for mGluR2
  • Metabolic Imaging in Parkinson Disease
  • Cerenkov Luminescence Imaging as a Modality to Evaluate Antibody-Based PET Radiotracers
  • Preclinical Pharmacokinetics and Biodistribution Studies of 89Zr-Labeled Pembrolizumab
  • A Systematic Approach for Developing Bacteria-Specific Imaging Tracers
  • Feasibility of Multiparametric Imaging with PET/MR in Head and Neck Squamous Cell Carcinoma
  • Red Marrow–Absorbed Dose for Non-Hodgkin Lymphoma Patients Treated with 177Lu-Lilotomab Satetraxetan, a Novel Anti-CD37 Antibody–Radionuclide Conjugate
  • Response Assessment Criteria and Their Applications in Lymphoma: Part 2
  • Effect of Carbidopa on 18F-FDOPA Uptake in Insulinoma: From Cell Culture to Small-Animal PET Imaging
  • 68Ga-PSMA-11 PET Imaging of Response to Androgen Receptor Inhibition: First Human Experience
  • Strategies to Inhibit ABCB1- and ABCG2-Mediated Efflux Transport of Erlotinib at the Blood–Brain Barrier: A PET Study on Nonhuman Primates
  • Comparison of the Impact of 68Ga-DOTATATE and 18F-FDG PET/CT on Clinical Management in Patients with Neuroendocrine Tumors
  • Characterization of 3-Dimensional PET Systems for Accurate Quantification of Myocardial Blood Flow
  • Diabetes Mellitus and Its Effects on All-Cause Mortality After Radiopeptide Therapy for Neuroendocrine Tumors
  • Metabolic Evaluation of Non–Small Cell Lung Cancer Patient–Derived Xenograft Models Using 18F-FDG PET: A Potential Tool for Early Therapy Response
  • The Controversial Linear No-Threshold Model
  • In Vivo 3-Dimensional Radiopharmaceutical-Excited Fluorescence Tomography
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • This Month in JNM
  • This Month in JNM
  • This Month in JNM
Show more This Month in JNM

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire